Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139222FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw materials and preparations, bio-engineering drugs, and nutritious and health products. Its product portfolio includes suxiao jiuxin wan, ticlopidine hydrochloride tablets, cold soft capsules, verapamil hydrochloride tablets, anti-bone hyperplasia pill, pregnant women jinhua tablets, and diarrhea and sputum tablets, and others. TZPG also conducts research and development to develop new pharmaceutical products. The company’s products are used to treat cardiovascular disease, cold, vomit, diarrhea, dyspepsia, chemotherapy, diabetes, skin diseases, gastrointestinal and pneumonia. TZPG is headquartered in Tianjin, China.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Key Recent Developments

Apr 01,2021: Zhongxin Pharm won the award of “2019 Top 100 Chinese National Medicine Brand Enterprises”
Mar 28,2021: Announcement of Zhongxin Pharmaceutical on the tender offer of Jinhushen Biomedical Technology Co., Ltd. to acquire company shares

This comprehensive SWOT profile of Tianjin Zhongxin Pharmaceutical Group Corp Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Information
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Overview
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employees
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employee Biographies
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Operational Heads
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Major Products and Services
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – History
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Company Statement
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Locations And Subsidiaries
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Business Description
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Corporate Strategy
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Strengths
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Weaknesses
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Opportunities
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Threats
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Information
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Ratios
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Share Data
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Major Products and Services
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, History
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employees
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employee Biographies
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Operational Heads
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Other Locations
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Subsidiaries
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Competitors
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, SWOT Analysis
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Ratios based on current share price
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Annual Ratios
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FleetCor Technologies, Inc.:企業のM&A・事業提携・投資動向
    FleetCor Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FleetCor Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Chiome Bioscience Inc (4583):製薬・医療:M&Aディール及び事業提携情報
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that provides research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating syst …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cadence Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Cadence Biomedical Inc (Cadence), formerly Empowering Engineering Technologies Corp, is a medical device company that provides mobility products. The company offers product such as Kickstart walking system. It provides product to individuals with severe mobility impairments. Cadence’s produc …
  • Alabama Municipal Electric Authority:電力:M&Aディール及び事業提携情報
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit publicly-owned electric utility that generates, procures, and supplies power. The authority generates electricity from sources such as gas and solar. AMEA procures electricity from open market and South Carolina Public Service A …
  • CIMIC Group Limited:企業のM&A・事業提携・投資動向
    CIMIC Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIMIC Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • EDF Renewable Energy Inc:電力:M&Aディール及び事業提携情報
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. It designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It develops …
  • UCB S.A.:企業のM&A・事業提携・投資動向
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Magnotta Winery Corporation:企業の戦略・SWOT・財務分析
    Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report Summary Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ambrx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ambrx Inc (Ambrx) is a biopharmaceutical company that offers discovery and development of protein-based medicines by using its expanded genetic code. The company provides pipeline product candidate’s portfolio such as ARX618 FGF21, PSMA ADC, CD70 ADC and Anti-CD3 X Folate. It develops pipeli …
  • University of Bath:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Bath (UOB) is an educational institution that provides educational and research services. The institute provides under graduate and post graduate programs in the fields of science, engineering and design, humanities and social sciences, and management studies. It also conducts …
  • La Plata Electric Association, Inc.:発電所・企業SWOT分析
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • MORRE-TEC Industries, Inc.:戦略・SWOT・企業財務分析
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SeraCare Life Sciences Inc:企業の戦略的SWOT分析
    SeraCare Life Sciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CMS Energy Corp (CMS):企業の財務・戦略的SWOT分析
    CMS Energy Corp (CMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • IHI Corporation (7013)-エネルギー分野:企業M&A・提携分析
    Summary IHI Corporation (IHI) is a heavy machinery engineering group. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products including ships and offshore facilit …
  • Brodrene Hartmann AS:戦略・SWOT・企業財務分析
    Brodrene Hartmann AS - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mazda Motor Corp (7261):企業の財務・戦略的SWOT分析
    Mazda Motor Corp (7261) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Arena Pharmaceuticals Inc (ARNA)-製薬・医療分野:企業M&A・提携分析
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. Its pipeline portfolio encompasses etrasimod for multiple inflammatory indications; ralinepag for the treatment of pulmonary arterial …
  • TOTAL S.A.:企業のM&A・事業提携・投資動向
    TOTAL S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TOTAL S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆